23 Hrs
Source:
BBC Home
BBC Home
Ready to play
Ready to play
Canada became the first G7 country to approve a generic version of semaglutide, the active ingredient in drugs like Ozempic and Wegovy, which are used for weight loss and diabetes management. The introduction of these generics is expected to significantly reduce costs, making GLP-1 medications more accessible to Canadians and potentially influencing prices in other countries like the US. While Canadian generics are already available, US patent laws delay similar approvals, with generics possibly not arriving until 2032.
Notice: This Is an AI-Generated Summary
Comments (0)